An Overview of Thalassemia Intermedia

Causes, Treatments, and More

Thalassemia is a group of blood disorders affecting hemoglobin, a protein that’s a component of red blood cells (RBC). People who inherit thalassemia are unable to produce hemoglobin normally, leading to anemia (low RBC count) and other complications.

A doctor talking to a patient about test results
Hero Images / Creative RF / Getty Images

Thalassemia can be broken into three categories:

  • Trait: Person carries the gene for mutation but does not have the disease. This is sometimes called thalassemia minor.
  • Intermedia: Person with thalassemia somewhere between trait and major.
  • Major: Person with thalassemia who requires lifelong RBC transfusions.


Although most of the time thalassemia major will be identified on the newborn screen, people with thalassemia intermedia may not be identified until years later. These people are generally identified during the process of a routine complete blood count (CBC). The CBC will reveal a mild to moderate anemia with very small red blood cells. This can easily be confused with iron deficiency anemia.

Diagnosis is confirmed by a hemoglobin profile (also called electrophoresis). In beta thalassemia intermedia and trait, this testing reveals an elevation in hemoglobin A2 (a second form of adult hemoglobin) and sometimes F (fetal). Alpha thalassemia intermedia is generally called hemoglobin H disease, as this is the predominant hemoglobin seen on the profile.


Complications of thalassemia intermedia include:

  • Iron overload
  • Osteoporosis: Weakening of the bones
  • Extramedullary hematopoiesis: This refers to enlargement of spleen, liver and/or bone marrow to increase red blood cell production. The bones most notably affected are in the skull—forehead and cheekbones.
  • Hypogonadism: Reduced maturation of sexual organs. This may prevent puberty from occurring naturally.
  • Gallstones
  • Blood clots


There are two reasons why people with thalassemia intermedia develop iron overload.

  1. Repeated red blood transfusions: Even though children with thalassemia intermedia generally don’t require transfusions every 3 to 4 weeks like children with thalassemia major, they still may require several blood transfusions every year. Each red blood transfusion received is like an intravenous (IV) dose of iron. The body does not have a great way to remove this iron from the body. So over time, these repeated transfusions may result in the development of iron overload, although generally later in life (adulthood) than people with thalassemia major (childhood).
  2. Increased absorption of iron from food: The body recognizes that the bone marrow is not doing a good job producing hemoglobin and red blood cells. Hepcidin is a protein that blocks the absorption of iron. In thalassemia, hepcidin levels are low, allowing more iron to be absorbed than is needed. It is recommended that people with thalassemia intermedia follow a low-iron diet and drink tea with meals as tea blocks the absorption of iron.


  • Routine medical care: Not every person with thalassemia intermedia will require treatment, but it is important to continue close medical care to monitor for complications.
  • Transfusions: People with thalassemia intermedia may require transfusions, but generally not as frequently as people with thalassemia major until adulthood. Transfusion may be needed in times of increased growth and development (puberty), illnesses (particularly those with fever), pregnancy, or in preparation for surgery.
  • Folic acid: Some physicians may recommend folic acid daily to support RBC production.
  • Splenectomy: In thalassemia, the spleen may enlarge (splenomegaly) in an effort to improve RBC production. This is often ineffective and may worsen anemia and/or increase transfusion need. In these circumstances, splenectomy may be considered.
  • Hydroxyurea: Hydroxyurea is a daily medication taken by mouth in an effort to increase hemoglobin, thereby reducing the need for RBC transfusions.
  • Low-iron diet: Because people with thalassemia intermedia are at risk to develop iron overload from increased absorption of iron in the diet, a low-iron diet may be recommended. Tea, particularly black tea, decreases the absorption of iron and may be recommended with meals.
  • Chelation: This treatment uses a medication that binds to iron, which is then eliminated from the body via urination or defecation.

Learning you have thalassemia intermedia can be shocking as you may not have had any symptoms. Be sure to follow up with your physician as scheduled so you can be monitored for potential complications.

1 Source
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Asadov C, Alimirzoeva Z, Mammadova T, Aliyeva G, Gafarova S, Mammadov J. β-Thalassemia intermedia: a comprehensive overview and novel approaches. Int J Hematol. 2018;108(1):5-21. doi:10.1007/s12185-018-2411-9

By Amber Yates, MD
Amber Yates, MD, is a board-certified pediatric hematologist and a practicing physician at Baylor College of Medicine.